<DOC>
	<DOC>NCT02199678</DOC>
	<brief_summary>This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging, placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of ketamine sublingual wafer in adult subjects who experience post operative pain after undergoing third molar extraction.</brief_summary>
	<brief_title>A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction</brief_title>
	<detailed_description />
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>18 38 years of age Scheduled to undergo two ipsilateral third molar extractions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>